CompletedNot Applicable

Prevalence of Acute Critical Neurological Disease in Children: a Global Epidemiological Assessment

922 participantsStarted 2011-11

Plain-language summary

PANGEA is an international prospective point prevalence study to describe the epidemiology, interventions, and outcomes in children with acute critical brain disease.

Who can participate

Age range7 Days – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Children aged 7 days to 17 years inclusively and admitted to an ICU (ICU can be classified as general, cardiac, trauma, etc).
✓. Children with acute or acute on chronic neurologic disease that occurred just prior to hospital admission or occurred during the hospital admission.
✓. Acute neurologic disease is secondary to TBI, stroke, brain mass, hydrocephalus, cardiac arrest, status epilepticus, CNS infection/inflammation, or spinal cord injury.

Exclusion criteria

✕. Children with acute perinatal neurologic disease.
✕. Children with isolated chronic brain injury and no acute neurologic disease.

What they're measuring

Prevalence of acute brain insult

Timeframe: 4 days over a 1 year period

Trial details

NCT IDNCT02381977

SponsorUniversity of Pittsburgh

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2012-10

View on ClinicalTrials.gov More Cardiac Arrest trials